Please assess the completion status of the following clinical trial:

Trial Title: A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Subject with normal renal function or renal impairment (mild, moderate, severe or end stage renal disease (ESRD) requiring haemodialysis)~* Body mass index maximum 40.0 kg/m\^2~Exclusion Criteria:~* Subject with any disease or condition which the Investigator feels would interfere with the trial except for conditions associated with renal impairment in the group of subjects with compromised renal function. Diabetes mellitus can be accepted in the group of patients with renal impairment, but not in subjects with normal renal function~* Subject who has donated any blood or plasma in the past month or more than 500 mL within 3 months prior to screening~* Significant history of alcoholism or drug/chemical abuse~* Not able or willing to refrain from smoking during the inpatient period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- ESRD (Type: EXPERIMENTAL): None
- Mild (Type: EXPERIMENTAL): None
- Moderate (Type: EXPERIMENTAL): None
- Normal (Type: EXPERIMENTAL): None
- Severe (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).